(Q30842506)

27 June 2017

1 reference

title

The herpesvirus proteases as targets for antiviral chemotherapy (English)

1 reference

27 June 2017

0 references

L Waxman

1

1 reference

PubMed ID

10693650

27 June 2017

P L Darke

series ordinal

2

1 reference

27 June 2017

1 January 2000

1 reference

Antiviral Chemistry & Chemotherapy

27 June 2017

1 reference

27 June 2017

11

1 reference

27 June 2017

1

1 reference

27 June 2017

1-22

1 reference

Expression of natural and synthetic genes encoding herpes simplex virus 1 protease in Escherichia coli and purification of the protein

27 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Sensitive substrates for human leukocyte and porcine pancreatic elastase: A study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Genital herpes simplex virus infections: clinical manifestations, course, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Stability of dimeric retroviral proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Active human cytomegalovirus protease is a dimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Structure and assembly of the virion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Autoprocessing of HSV-1 protease: effect of deletions on autoproteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Activation of the herpes simplex virus type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester s

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Herpesvirus proteases: targets for novel antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Three new human herpesviruses (HHV6, 7, and 8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Differentiation of multiple domains in the herpes simplex virus 1 protease encoded by the UL26 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Use of steady state kinetic methods to elucidate the kinetic and chemical mechanisms of retroviral proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

The effect of internal autocleavage on kinetic properties of the human cytomegalovirus protease catalytic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Identification of a novel peptide substrate of HSV-1 protease using substrate phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Peptidomimetic inhibitors of the human cytomegalovirus protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Quanolirones I and II, two new human cytomegalovirus protease inhibitors produced by Streptomyces sp. WC76535.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Unique fold and active site in cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Crystal structure of varicella-zoster virus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Crystal structures of the complex of porcine pancreatic elastase with two valine-derived benzoxazinone inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Domain flexibility in aspartic proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Dimerization and activation of the herpes simplex virus type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Three-dimensional structure of the HSV1 nucleocapsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Three-dimensional structure of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Inhibition of human cytomegalovirus proteinase by salcomine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

The adenovirus protease is activated by a virus-coded disulphide-linked peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

beta-Lactam derivatives as inhibitors of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

Potent beta-lactam inhibitors of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100101

10.1177/095632020001100101

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

10693650